Home  >  Products  >  BAT3 (BCL2-associated athanogene 6 ) Blocking Peptide (the C terminal of BAT3)(100ug)
BAT3 (BCL2-associated athanogene 6 ) Blocking Peptide (the C terminal of BAT3)(100ug)

BAT3 (BCL2-associated athanogene 6 ) Blocking Peptide (the C terminal of BAT3)(100ug)

Supplier: Aviva Systems Biology Incorporated
Star_fadedStar_fadedStar_fadedStar_fadedStar_faded
0 reviews | Write a Review Pencil
This is a synthetic peptide designed for use in combination with anti-BAT3 Antibody (ARP61643_P050), made by Aviva Systems Biology. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.
Reactivities: Human
Presku: AAP61643
Size: 100ug
Weight: 125kDa
Gene: The peptide is characterized by mass spectroscopy
Format: Lyophilized powder
Target: This gene was first characterized as part of a cluster of genes located within the human major histocompatibility complex class III region. This gene encodes a nuclear protein that is cleaved by caspase 3 and is implicated in the control of apoptosis. In addition, the protein forms a complex with E1A binding protein p300 and is required for the acetylation of p53 in response to DNA damage.
Alternative names: BAG-6; BAG6; D6S52E; G3
See Full Product Listings >